Metro Healthcare Berhad (KLSE:METRO)
Malaysia
· Delayed Price · Currency is MYR 0.225
+0.005 (2.27%)
At close: Dec 5, 2025
Metro Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 48.75 | 48.65 | 44.69 | 40.27 | 42.26 | 28.33 | Upgrade
|
| Revenue Growth (YoY) | 1.00% | 8.87% | 10.96% | -4.70% | 49.14% | 24.77% | Upgrade
|
| Cost of Revenue | 31.25 | 28.92 | 26.61 | 24.27 | 22.16 | 15.15 | Upgrade
|
| Gross Profit | 17.5 | 19.73 | 18.08 | 16.01 | 20.09 | 13.18 | Upgrade
|
| Other Operating Expenses | 11.97 | 12.32 | 9.21 | 8.71 | 8.11 | 7.46 | Upgrade
|
| Operating Expenses | 11.97 | 12.32 | 9.21 | 8.71 | 8.11 | 7.46 | Upgrade
|
| Operating Income | 5.53 | 7.4 | 8.87 | 7.3 | 11.98 | 5.72 | Upgrade
|
| Interest Expense | -0.65 | -0.69 | -0.73 | -0.4 | -0.37 | -0.39 | Upgrade
|
| Interest & Investment Income | 0.46 | 0.46 | 0.21 | 0.17 | 0.11 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | 5.35 | 7.17 | 8.35 | 7.07 | 11.72 | 5.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.08 | 0.79 | 1.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.03 | 0.22 | 0.02 | - | Upgrade
|
| Other Unusual Items | - | - | 0.16 | 0 | 0.07 | 0.05 | Upgrade
|
| Pretax Income | 5.35 | 7.17 | 8.54 | 7.38 | 12.6 | 7.27 | Upgrade
|
| Income Tax Expense | 2.31 | 2.61 | 2.29 | 2.36 | 3.17 | 1.79 | Upgrade
|
| Net Income | 3.03 | 4.56 | 6.25 | 5.02 | 9.44 | 5.48 | Upgrade
|
| Net Income to Common | 3.03 | 4.56 | 6.25 | 5.02 | 9.44 | 5.48 | Upgrade
|
| Net Income Growth | -53.54% | -27.02% | 24.56% | -46.85% | 72.32% | 142.76% | Upgrade
|
| Shares Outstanding (Basic) | 1,096 | 979 | 822 | 822 | 822 | 808 | Upgrade
|
| Shares Outstanding (Diluted) | 1,096 | 979 | 822 | 827 | 822 | 808 | Upgrade
|
| Shares Change (YoY) | 33.33% | 19.05% | -0.55% | 0.55% | 1.82% | 0.62% | Upgrade
|
| EPS (Basic) | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | -65.25% | -38.70% | 24.56% | -46.86% | 69.25% | 141.32% | Upgrade
|
| Free Cash Flow | 7.28 | 5.58 | 7.38 | 4.67 | 7.21 | 2.73 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
| Dividend Per Share | 0.006 | 0.005 | 0.005 | 0.005 | 0.002 | 0.002 | Upgrade
|
| Dividend Growth | 20.37% | 1.89% | 6.00% | 212.50% | 6.67% | 7.14% | Upgrade
|
| Gross Margin | 35.91% | 40.55% | 40.46% | 39.74% | 47.55% | 46.53% | Upgrade
|
| Operating Margin | 11.35% | 15.22% | 19.85% | 18.12% | 28.36% | 20.18% | Upgrade
|
| Profit Margin | 6.22% | 9.37% | 13.98% | 12.46% | 22.33% | 19.33% | Upgrade
|
| Free Cash Flow Margin | 14.93% | 11.46% | 16.52% | 11.60% | 17.05% | 9.62% | Upgrade
|
| EBITDA | 8.95 | 10.62 | 11.66 | 9.97 | 13.99 | 7.22 | Upgrade
|
| EBITDA Margin | 18.37% | 21.84% | 26.10% | 24.76% | 33.10% | 25.47% | Upgrade
|
| D&A For EBITDA | 3.42 | 3.22 | 2.79 | 2.68 | 2.01 | 1.5 | Upgrade
|
| EBIT | 5.53 | 7.4 | 8.87 | 7.3 | 11.98 | 5.72 | Upgrade
|
| EBIT Margin | 11.35% | 15.22% | 19.85% | 18.12% | 28.36% | 20.18% | Upgrade
|
| Effective Tax Rate | 43.25% | 36.43% | 26.86% | 32.01% | 25.12% | 24.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.